Q3 2020 Holdings
Filed 2020-11-13 | 10 holdings | $1.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $1.8M | 684,912 | 93.0% |
| Myokardia, Inc. | COM | 62857M105 | $54.4K | 399,360 | 2.9% |
| Natera, Inc.(NTRA) | COM | 632307104 | $15.1K | 208,768 | 0.8% |
| Oric Pharmaceuticals, Inc. | COM | 06822P109 | $12.4K | 496,893 | 0.7% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $12.2K | 108,630 | 0.6% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $11.9K | 998,278 | 0.6% |
| Cymabay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $11.9K | 1,641,804 | 0.6% |
| FibroGen, Inc.(FGENEUR) | COM | 31572Q808 | $7.1K | 172,500 | 0.4% |
| Verona Pharma plc(VRNA) | SPONS ADS | 925050106 | $6.9K | 1,111,112 | 0.4% |
| Novavax, Inc.(NVAX) | COM | 670002401 | $542 | 5,000 | 0.0% |